Lin Hou

Dr. Lin Hou


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JMJiacheng Miao
Jiacheng Miao
HGHanmin Guo
Hanmin Guo
GSGefei Song
Gefei Song
ZZZijie Zhao
Zijie Zhao
LHLin Hou
Lin Hou
QLQiongshi Lu
Qiongshi Lu
Polygenic risk scores (PRS) calculated from genome-wide association studies (GWAS) of Europeans are known to have substantially reduced predictive accuracy in non-European populations, limiting their clinical utility and raising concerns about health disparities across ancestral populations. Here, we introduce a statistical framework named X-Wing to improve predictive performance in ancestrally diverse populations. X-Wing quantifies local genetic correlations for complex traits between populations, employs an annotation-dependent estimation procedure to amplify correlated genetic effects between populations, and combines multiple population-specific PRS into a unified score with GWAS summary statistics alone as input. Through extensive benchmarking, we demonstrate that X-Wing pinpoints portable genetic effects and substantially improves PRS performance in non-European populations, showing 14.1%–119.1% relative gain in predictive R2 compared to state-of-the-art methods based on GWAS summary statistics. Overall, X-Wing addresses critical limitations in existing approaches and may have broad applications in cross-population polygenic risk prediction.

1 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHanmin Guo
Hanmin Guo
JLJames J. Li
James J. Li
QLQiongshi Lu
Qiongshi Lu
LHLin Hou
Lin Hou
Genetic correlation analysis has quickly gained popularity in the past few years and provided insights into the genetic etiology of numerous complex diseases. However, existing approaches oversimplify the shared genetic architecture between different phenotypes and cannot effectively identify precise genetic regions contributing to the genetic correlation. In this work, we introduce LOGODetect, a powerful and efficient statistical method to identify small genome segments harboring local genetic correlation signals. LOGODetect automatically identifies genetic regions showing consistent associations with multiple phenotypes through a scan statistic approach. It uses summary association statistics from genome-wide association studies (GWAS) as input and is robust to sample overlap between studies. Applied to seven phenotypically distinct but genetically correlated neuropsychiatric traits, we identify 227 non-overlapping genome regions associated with multiple traits, including multiple hub regions showing concordant effects on five or more traits. Our method addresses critical limitations in existing analytic strategies and may have wide applications in post-GWAS analysis.

29 March 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
Nayang ShanNayang Shan
Nayang Shan
ZWZuoheng Wang
Zuoheng Wang
LHLin Hou
Lin Hou
Mapping expression quantitative trait loci (eQTLs) has provided insight into gene regulation. Compared to cis-eQTLs, the regulatory mechanisms of trans-eQTLs are less known. Previous studies suggest that trans-eQTLs may regulate expression of remote genes by altering the expression of nearby genes. Trans-association has been studied in the mediation analysis with a single mediator. However, prior applications with one mediator are prone to model misspecification due to correlations between genes. Motivated from the observation that trans-eQTLs are more likely to associate with more than one cis-gene than randomly selected SNPs in the GTEx dataset, we developed a computational method to identify trans-eQTLs that are mediated by multiple mediators. We proposed two hypothesis tests for testing the total mediation effect (TME) and the component-wise mediation effects (CME), respectively. We demonstrated in simulation studies that the type I error rates were controlled in both tests despite model misspecification. The TME test was more powerful than the CME test when the two mediation effects are in the same direction, while the CME test was more powerful than the TME test when the two mediation effects are in opposite direction. Multiple mediator analysis had increased power to detect mediated trans-eQTLs, especially in large samples. In the HapMap3 data, we identified 11 mediated trans-eQTLs that were not detected by the single mediator analysis in the combined samples of African populations. Moreover, the mediated trans-eQTLs in the HapMap3 samples are more likely to be trait-associated SNPs. In terms of computation, although there is no limit in the number of mediators in our model, analysis takes more time when adding additional mediators. In the analysis of the HapMap3 samples, we included at most 5 cis-gene mediators. Majority of the trios we considered have one or two mediators. Trans-eQTLs are more likely to associate with multiple cis-genes than randomly selected SNPs. Mediation analysis with multiple mediators improves power of identification of mediated trans-eQTLs, especially in large samples.

11 February 2020 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
SSShuang Song
Shuang Song
WJWei Jiang
Wei Jiang
LHLin Hou
Lin Hou
HZHongyu Zhao
Hongyu Zhao
Genetic risk prediction is an important problem in human genetics, and accurate prediction can facilitate disease prevention and treatment. Calculating polygenic risk score (PRS) has become widely used due to its simplicity and effectiveness, where only summary statistics from genome-wide association studies are needed in the standard method. Recently, several methods have been proposed to improve standard PRS by utilizing external information, such as linkage disequilibrium and functional annotations. In this paper, we introduce EB-PRS, a novel method that leverages information for effect sizes across all the markers to improve prediction accuracy. Compared to most existing genetic risk prediction methods, our method does not need to tune parameters nor external information. Real data applications on six diseases, including asthma, breast cancer, celiac disease, Crohn’s disease, Parkinson’s disease and type 2 diabetes show that EB-PRS achieved 307.1%, 42.8%, 25.5%, 3.1%, 74.3% and 49.6% relative improvements in terms of predictive r2 over standard PRS method with optimally tuned parameters. Besides, compared to LDpred that makes use of LD information, EB-PRS also achieved 37.9%, 33.6%, 8.6%, 36.2%, 40.6% and 10.8% relative improvements. We note that our method is not the first method leveraging effect size distributions. Here we first justify our method by presenting theoretical optimal property over existing methods in this class of methods, and substantiate our theoretical result with extensive simulation results. The R-package EBPRS that implements our method is available on CRAN. Genetic risk prediction is of considerable importance in human genetics. Calculating polygenic risk score (PRS) is the most commonly used approach due to its simplicity as well as the computational efficiency. Many PRS calculation methods have been proposed for accurate prediction by borrowing information from external panels or datasets. Here, instead of external information, we propose a novel PRS method leveraging internal information, namely the effect size distributions, to improve prediction accuracy. Neither parameter tuning nor external information is needed for our method. Extensive simulations and real data applications demonstrate that our method has substantial improvement over existing methods in terms of prediction accuracy.

28 September 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RLRuiyun Li
Ruiyun Li
BCBin Chen
Bin Chen
TZTao Zhang
Tao Zhang
ZRZhehao Ren
Zhehao Ren
Yimeng SongYimeng Song
Yimeng Song
BXBing Xu
Bing Xu
Significance: By linking seasonality of climate and changing human behavior, we demonstrate that collaboration on global efforts for prompt and intensive intervention is fundamental to coping with future pandemic waves of COVID-19. We propose that this collaboration can be started in locations with typically high population density and international travel, followed by other high-risk locations. We believe this tiered intervention strategy can greatly integrate global efforts and is effective and practical to improve the global emergency response to COVID-19 and many other infectious diseases.

10 August 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Nayang ShanNayang Shan
Nayang Shan
NLNingshan Li
Ningshan Li
QDQile Dai
Qile Dai
LHLin Hou
Lin Hou
XYXiting Yan
Xiting Yan
ZWZuoheng Wang
Zuoheng Wang
Effector CD8+ T cell activation and its cytotoxic function are positively correlated with improved survival in breast cancer. tRNA-derived fragments (tRFs) have recently been found to be involved in gene regulation in cancer progression. However, it is unclear how interactions between expression of tRFs and T cell activation affect breast cancer patient survival. We used Kaplan–Meier survival and multivariate Cox regression models to evaluate the effect of interactions between expression of tRFs and T cell activation on survival in 1081 breast cancer patients. Spearman correlation analysis and weighted gene co-expression network analysis were conducted to identify genes and pathways that were associated with tRFs. tRFdb-5024a, 5P_tRNA-Leu-CAA-4-1, and ts-49 were positively associated with overall survival, while ts-34 and ts-58 were negatively associated with overall survival. Significant interactions were detected between T cell activation and ts-34 and ts-49. In the T cell exhaustion group, patients with a low level of ts-34 or a high level of ts-49 showed improved survival. In contrast, there was no significant difference in the activation group. Breast cancer related pathways were identified for the five tRFs. In conclusion, the identified five tRFs associated with overall survival may serve as therapeutic targets and improve immunotherapy in breast cancer.